Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 16/20 | 0.74 |
| ▸ | PDE4B | Q07343 | 15/20 | 0.74 |
| ▸ | PDE4C | Q08493 | 15/20 | 0.74 |
| ▸ | PDE4D | Q08499 | 15/20 | 0.74 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4716894 | 0.94 | PDE4A (0.83) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL4716891 | 0.94 | PDE4A (0.83) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL6249049 | 0.94 | PDE4A (0.83) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL8313995 | 0.89 | PDE4A (0.88) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| Bicarbonate SCHEMBL4719348 | 0.88 | KCNH2 (0.74) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL8319498 | 0.87 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4717053 | 0.85 | PDE4A (0.83) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL20755890 | 0.85 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL4714294 | 0.85 | PDE4A (0.83) | PDE4APDE4BPDE4CPDE4DKCNH2 | |
| SCHEMBL6248001 | 0.85 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004048374-A1 | 4-OXO-1-(3-SUBSTITUTED PHENYL-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE PHOSPHODIESTERASE-4 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2004-06-10 | — | — | WO | disclosed |